Skip to Main Content

WASHINGTON — Sens. Elizabeth Warren (D-Mass.) and Shelley Moore Capito (R-W.Va.) wrote a series of letters on Wednesday asking major figures in the battle against the nation’s opioid epidemic to consider promoting and analyzing “partial fill” policies, which allow patients to receive less than a full prescription’s worth of medication on a single pharmacy trip.

A clause in the Comprehensive Addiction and Recovery Act, passed in 2016, permits pharmacies to dispense portions of prescriptions for Schedule II drugs — a classification that includes many opioid-based painkillers with high potential for abuse — and for patients to return later if they feel the remainder of prescribed medication is needed.

advertisement

“Our idea was simple: empower patients to have a conversation with their health providers and pharmacists about how many prescription drugs they felt comfortable having in their home,” Warren and Capito wrote in letters to FDA Commissioner Scott Gottlieb; all 50 state governors;  11 major medical member organizations; and Massachusetts Health Commissioner Monica Bharel.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect

To submit a correction request, please visit our Contact Us page.